Carnival of Biotechnology - March 27, 2007
Welcome to the March 27th version of the Carnival of Biotechnology. Thanks to Yali for letting me guest host the carnival. If you’d like to enter a post for a later edition or maybe even guest host, see the Carnival of Biotechnology submission and host information page.
These weren’t submitted to the carnival, but I think they’re worth the read, so they get their own section:
If you haven’t read it yet, I have a post on whether Progression-free survival is a good end point to measure for clinical trials.
Finance and Business Development
Yali Friedman talks about how venture capital companies are decreasing their funding of startup biotechs and that angels are filling the biotechnology funding gap at Biotech Blog.Â Now if I could only find some rich guy/gal (Angel) to do research for, I’d be a happy camper.
Derek Lowe discusses the future of Atherogenics’ drug AGI-1067 which failed its phase 3 trial in his post AGI-1067: Dead or Alive? at In the Pipeline.
Regulations and Politics
David Williams has a suggestion for the Senators on the Health, Education, Labor and Pensions Committee about how to keep the price of biologics low but still safe in his post Senators still seem to be missing the point on generic biologics at Health Business Blog.
Yali Friedman talks about the clash between governments need for reasonably priced drugs during “crises” and companies’ desire to defend their patents and make money in his post Price controls and compulsory licensing give buyers more power â€¦ for a price at Biotech Blog.
Attila Csordas has a proposal for the beloved section of the scientific paper that doesn’t make it into the journal, but is (sometimes) worth looking at: Letâ€™s make â€™supplementaryâ€™ peer-review scientific videos free and youtubish! posted at Pimm - Partial immortalization.
And that concludes this week’s carnival.Â If you’re interested in investing in stocks, I’ve got a post in the Festival of Stocks.Â I think I was the only biotechnology stock, but then again, you’re not investing in just biotechs, are you?Â Go have a read once you’re done with this weeks carnival.
Filed under: Blog Carnivals and Other Links